Abstract
The aim of this study was to compare the graft patency rates among patients who had a previous history of percutaneous coronary intervention (PCI) followed by coronary artery bypass grafting surgery (CABG) with the patients who had experienced CABG surgery alone. The 69 patients who were included in the study had a history of bare metal stent implantation prior to CABG (group 1). The coronary angiography results were compared with 69 patients who had a previous history of CABG (group 2). Graft patency rates of the left anterior descending artery and circumflex anastomoses are statistically significant for both groups, whereas the right coronary artery anastomoses are not statistically significant (p = 0.008; 0.009; 0.2). Graft patency rate of LIMA–LAD anastomoses was 43.9 ± 10.8 % in group 1 and 86.2 ± 6 % in group 2 for means of 60 months (p = 0.0001) and circumflex coronary artery anastomosis is 28.9 ± 0.9 % in group 1, 65.7 ± 10.8 % in group 2 (p = 0.0001) and the right coronary artery anastomosis is 37.2 ± 13.6 % in group 1, 56.4 ± 8.9 % in group 2 (p = 0.0001). The graft patency rates of coronary arteries without previous stent implantation were higher than the patients with previous stent implantation and experienced CABG. The results suggest that prior PCI may induce atherosclerotic events in the vessel that can adversely affect graft patency after surgery.
Similar content being viewed by others
References
Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O’Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y (2007) A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115:69–171
Investigators SoS (2002) Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 360:965–970
Serruys PW, Ong ATL, van Herwerden LA, Sousa JE (2005) Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46:575–581
Rodriguez AE, Baldi J, Fernández PC, Jose N, Máximo RA, Alejandro D, Vigo F, Vogel D, O’Neil W, Palacios IF (2005) Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 46:582–588
Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, Culliford AT, Isom OW, Gold JP, Rose EA (2005) Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352:2174–2183
Cutlip DE, Chhabra AG, Baim DS, Chauhan MS, Marulkar S, Massaro J, Bakhai A, Cohen DJ, Kuntz RE, Ho KK (2004) Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation 110:1226–1230
Keogh B (2003) Fifth National Adult Cardiac Surgical Database Report: improving outcomes for patients. Dendrite Clinical Systems, Henley-on-Thames, p 352
Kalaycioglu S, Sinci V, Oktar L (1998) Coronary artery bypass grafting (CABG) after successful percutaneous transluminal coronary angioplasty (PTCA): is PTCA a risk for CABG? Int Surg 83:190–193
Barakate MS, Hemli JM, Hughes CF, Bannon PG, Horton MD (2003) Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience. Eur J Cardiothorac Surg 23:179–186
Kamiya H, Ushijima T, Mukai K, Ikeda C, Ueyama K, Watanabe G (2004) Late patency of the left internal thoracic artery graft in patients with and without previous successful percutaneous transluminal coronary angioplasty. Interact Cardiovasc Thorac Sur 3:110–113
Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, O’Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E (2005) One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 130:512–519
Massoudy P, Thielmann M, Lehmann N, Marr A, Kleikamp G, Maleszka A, Zittermann A, Körfer R, Radu M, Krian A, Litmathe J, Gams E, Sezer O, Scheld H, Schiller W, Welz A, Dohmen G, Autschbach R, Slottosch I, Wahlers T, Neuhäuser M, Jöckel KH, Jakob H (2009) Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis. J Thorac Cardiovasc Surg 137:840–845
Thielmann M, Leyh R, Massoudy P, Neuhäuser M, Aleksic I, Kamler M, Herold U, Piotrorwski J, Jacob H (2006) Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery. Circulation 114(1 Suppl):1441–1447
Hassan A, Buth KJ, Baskett RJ, Ali IS, Maitland A, Sullivan JA, Ghali WA, Hirsch GM (2005) The association between prior percutaneous coronary intervention and short-term outcomes after coronary artery bypass grafting. Am Heart J 150:1026–1031
Bonaros N, Hennerbichler D, Friedrich G, Kocher A, Pachinger O, Laufer G, Bonatti J (2009) Increased mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 137:846–852
Rao C, De Lisle R, Chikwe J, Pepper J, Skapinakis P, Aziz O, Darzi A, Athanasiou T (2008) Does previous percutaneous coronary stenting compromise the long-term efficacy of subsequent coronary artery bypass surgery? A microsimulation study. Ann Thorac Surg 85:501–507
Chocron S, Baillot R, Roucleau JL, Warnica WJ, Block P, Johnstone D, Myers MG, Calciu CD, Nozza A, Martineau P, van Gilst WH (2008) Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularisation on outcomes after surgical revascularisation: insights from the IMAGINE study. Eur Heart J 29:573–575
Mack MJ, Osborne JA, Shennib H (1998) Arterial graft patency in coronary artery bypass grafting: what do really know? Ann Thorac Surg 66:1055–1059
Farb A, Sangiorgi G, Carter A, Walley VM, Edwards W, Schwartz RS, Virmani R (1999) Pathology of acute and chronic coronary stenting in humans. Circulation 99:44–52
Jang Y, Lincoff AM, Plow EF, Topol EJ (1994) Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 24:1591–1601
Zotz RB, Klein M, Dauben HP, Moser C, Gams E, Schafrf RE (2000) Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death. Thromb Haemost 83:404–407
Horvath KA, Parker MA, Frederiksen JW, Palmer AS, Fullerton DA (2000) Postoperative troponin I values: insult or injury? Clin Cardiol 32:731–735
Taguchi I, Yoneda S, Abe S, Toyoda S, Nasuno T, Nishino S, Kageyama M, Tokura M, Ogawa M, Node K, Inoue T (2014) The late-phase inflammatory response after drug-eluting stent implantation. Heart Vessels 29:213–219
Sarkar R, Webb RC (1998) Does nitric oxide regulates smooth muscle cell proliferation? J Vasc Res 35:135–142
Groves PH, West JL (2000) Nitric oxide generating polymers reduced platelet adhesion and smooth muscle cell proliferation. Biomaterials 21:2273–2278
Chen CY, Hanson SR, Keefer LK, Saavedra JE, Davies KM, Hutsell TC, Hughes JD, Ku DN, Lumsden AB (1997) Boundary layer infusion of nitric oxide reduces early smooth muscle cell proliferation in the endarterectomized canine artery. J Surg Res 67:26–32
Luscher TF, Diedrich D, Siebenmann R, Lehmann K, Stulz P (1988) Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 319:462–467
Alagem-Shafir M, Kivovich E, Tzchori I, Lanir N, Falah M, Flugelman MY, Dinnar U, Beyar R, Lotan N, Sivan SS (2014) The formation of an anti-restenotic/anti-thrombotic surface by immobilization of nitric oxide synthase on a metallic carrier. Acta Biomater 10:2304–2312
Tuomainen PO, Ylitalo A, Niemela M, Kervinen K, Pietila M, Sia J, Nyman K, Nammas W, Airaksinen KE, Karjalainen PP (2013) Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial. Int J Cardiol 30(168):1214–1219
Karjalainen PP, Niemelä M, Airaksinen JK, Rivero-Crespo F, Romppanen H, Sia J, Lalmand J, de Bruyne B, Debelder A, Carlier M, Nammas W, Ylitalo A, Hess OM; BACE-ACS study investigators (2012) A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: EuroIntervention 8: 306–315
Conflict of interest
We have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Songur, M.Ç., Özyalçin, S., Özen, A. et al. Does really previous stenting affect graft patency following CABG? A 5-year follow-up. Heart Vessels 31, 457–464 (2016). https://doi.org/10.1007/s00380-015-0633-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-015-0633-9